Class Week Starting On 11.03.2019
Class Week Starting On 11.03.2019
NPV
EAW
Rate of int 10%
Amount
End of
of
Period
Deposit
0 800
1-9 1500
10 0
Method A will involve purchasing a machine for $50,000 with a life of 5 years, a $2,000 salvage value and a fixed annual oper
$10,000. Additionally, each part produced by the method will cost $10.
Method B will involve purchasing the part from a subcontractor for $25 per part.
At an interest rate of 10% per year, what is the number of parts per year required for the two methods to break even. (that is
is the same irrespective of the method used)
ge value and a fixed annual operating cost of
NPV
Future Value
Eqtd Yrly Amt (using FV)
Eqtd Yrly Amt (using PV)
FV from pmt
PV from pmt
Fill in the cells coloured.
Case Acron Pharma
Acron is a large drug company. One of its new drugs, Niagara, is coming to market and Acron needs
how much annual production capacity to build for this drug. Government regulations make it difficu
capacity at a later date, so Acron must determine capacity recommendation before the drug comes
drug will be sold for 20 years before it comes off patent. After 20 years, the right to produce the dru
worthless. Acron has made the following assumptions:
Year 1 demand will be 10,000 units
During years 2-6, annual growth of demand will be 15%
During years 7-20, annual growth rate will be 5%
It costs $6, payable at the end of year 1 to build each unit of annual production capacity. The cost of
capacity is depreciated at a straight line 5-year basis.
During year 1, Niagara will sell for $8 per unit and will incur a variable cost of $5 to produce.
Cost of maintaining a unit of capacity during year 1 is $1.
The unit price, unit variable cost and unit capacity maintenance cost will increase by 5% per year.
Profits are taxed at 40%
All cash flows are assumed to incur at the end of each year and the corporate discount rate is 10%.
Acron wants to develop a spreadsheet model of its 20-year cash flows. Then it wants to answer the
questions:
What capacity level should be chosen?
How does a change in the discount rate affect the optimal capacity level?
ming to market and Acron needs to determine
ment regulations make it difficult to add
endation before the drug comes to market. The
ars, the right to produce the drug will be
le cost of $5 to produce.
evel?